Advertisement
Advertisement
SEER
Seer, Inc. Class A Common Stock
1.79
USDSponsored
+0.04
+2.57%
Feb 06, 15:54 UTC -5
Closed
After-Market
1.79
0.00
0.00%
SEER Earnings Reports
Positive Surprise Ratio
SEER beat 13 of 20 last estimates.
65%
Next Report
Date of Next Report
Feb 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
$4.69M
/-$0.32
Implied change from Q3 25 (Revenue/ EPS)
+13.86%
/--
Implied change from Q4 24 (Revenue/ EPS)
+17.30%
/-20.00%
Seer, Inc. Class A Common Stock earnings per share and revenue
On Nov 06, 2025, SEER reported earnings of -0.32 USD per share (EPS) for Q3 25, missing the estimate of -0.30 USD, resulting in a -4.58% surprise. Revenue reached 4.12 million, compared to an expected 4.08 million, with a 1.00% difference. The market reacted with a -3.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 4.69 million USD, implying an increase of 0.00% EPS, and increase of 13.86% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Biogen Inc. Common Stock
Report Date
Feb 06, 2026 For Q4 25
Estimate
$1.62
Actual
$1.99
Surprise
+22.39%
Illumina Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.24
Actual
$1.35
Surprise
+8.01%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Arrowhead Research Corporation
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.25
Actual
$0.22
Surprise
-14.76%
Immunovant, Inc. Common Stock
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.61
Surprise
+16.27%
Adaptive Biotechnologies Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.09
Surprise
+51.33%
FAQ
What were Seer, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Seer, Inc. Class A Common Stock reported EPS of -$0.32, missing estimates by -4.58%, and revenue of $4.12M, 1% above expectations.
How did the market react to Seer, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved down -3.24%, changed from $2.16 before the earnings release to $2.09 the day after.
When is Seer, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Feb 26, 2026.
What are the forecasts for Seer, Inc. Class A Common Stock's next earnings report?
Based on 3
analysts, Seer, Inc. Class A Common Stock is expected to report EPS of -$0.32 and revenue of $4.69M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement